Vibrant America Neural Zoomer Plus Test

Expansive Neurological Auto-Antibody Test

Single Patient Blood Test

The Neural Zoomer Plus is an array of 48 of the most common autoantibodies associated with neurological autoimmunity and cognitive decline, which offers very specific antibody-to-antigen recognition. The Vibrant Neural Zoomer Plus is designed to assess an individual’s reactivity to 48 neurological antigens, which may have connections to a variety of neurologically related diseases. Neural Zoomer Plus Sample Report

The test also has optional additional genetic testing for the ApoE genotype, which has been shown to influence risk for certain neurological conditions.

With a panel of 48 of the most well-studied neurological autoantibodies, the Neural Zoomer Plus is able to pinpoint the mechanisms behind disease progression to help provide a roadmap to solutions and improved health outcomes in this challenging arena of disease. The Vibrant Neural Zoomer Plus aims to reduce the prevalence of neurological conditions by empowering patients and physicians with a vital resource for early risk detection and an enhanced focus on personalised primary prevention.

Markers Measured:

Demyelination Antigens

Anti-Tubulin: Associated with alcoholic liver disease, demyelinating disease, Grave’s disease, Hashimoto’s thyroiditis, infectious agent exposure PANDAS/ANDAS/OCD, rheumatoid arthritis, and recent onset type 1 diabetes.
Anti-Myelin basic protein: Related to the risk for multiple sclerosis, autism, PANDAS/ANDAS/OCD, and systemic lupus erythematosus (SLE).
Anti-Myelin oligodendrocyte glycoprotein (MOG): Found in various demyelinating diseases, including multiple sclerosis, neuromyelitis optica spectrum disorders (NMOSD), idiopathic optic neuritis (ON), acute disseminated encephalomyelitis (ADEM), multiphasic disseminated encephalomyelitis (MDEM), Devic’s disease, and tumefactive demyelinating disease.
Anti-Myelin proteolipid protein: A useful marker in patients with seronegative anti-myelin basic protein, the frequent marker in active multiple sclerosis and optic neuritis.
Anti-Neurofascin: Found mainly in combined central and peripheral demyelination (CCPD), a rare demyelinating condition affecting both CNS and peripheral nervous system (PNS) tissues, and also in chronic inflammatory demyelinating polyneuropathy (CIDP) and axonal injury in patients with multiple sclerosis (MS).
Anti-MAG: Anti-MAG peripheral neuropathy is a very rare disease caused by anti-MAG antibodies that destroy MAG protein leading to disruptions of normal myelin production and healthy peripheral nerve activity.

Blood Brain Barrier Disruption

Anti-s100b: Blood brain barrier integrity breach and sub-concussive episodes lead to the production of this antibody. Extravasated s100B may trigger a pathologic autoimmune reaction linking systemic and CNS immune responses.
Anti-Glial fibrillary acidic protein: Anti-GFAP is produced when the protein enters the bloodstream after a rupture of the blood brain barrier, thus serves as a blood based diagnostic marker of brain injury.
Anti-Microglia: Indicate a destruction of the blood brain barrier and are found to play a role in tissue destruction of Alzheimer’s disease.
Anti-Glucose regulated protein 78: Glucose-regulated protein 78–targeted antibodies could instigate bloodbrain barrier breakdown and development of hallmark anti–aquaporin-4 autoantibody pathology.

Optical and Autonomic Nervous System Disorders

Anti-Neuron specific enolase: Antibodies against neuron specific enolase are found in patients with optical neuropathies.
Anti-Aquaporin 4: AQP4 IgG is involved in the development of neuromyelitis optica and revolutionized the understanding of the disease. Anti-Aquaporin4 antibodies have also been shown in patients with peripheral demyelination.
Anti-Recoverin: One of the key components of antibody disorders of the CNS. They have also been shown to be associated with retinopathy which is characterized by impaired vision and photosensitivity.
Anti-CV2: Seen in autoimmune paraneoplastic autonomic neuropathy and mixed axonal and demyelinating peripheral neuropathy

Peripheral Neuropathy

Anti-GM1: Associated with multi-focal motor neuropathy and lower motor neuropathy, characterized by muscle weakness and atrophy
Anti-GM2: A potential peripheral nerve antigen for neuropathy-associated autoantibodies
Anti-Hu: The most frequent manifestation of sensory neuropathy with frequent autonomic involvement
Anti-Ri: Can be detected in patients with the paraneoplastic opsoclonus/myoclonus syndrome. Neoplasms most often associated with anti-Ri include breast cancer, gynecological cancers, and small cell lung cancer.
Anti-Amphiphysin: Often found in the serum of patients with stiff-person syndrome

Neuromuscular disorders

Anti-Acetylcholine receptors: Found in myasthenia gravis disease which destroys the receptor function, leading to a neuromuscular transmission defect, which then causes hypofunction, fatigue, and inflammation of skeletal muscles and produces serum antibodies against muscle antigens
Anti-Muscle specific kinase: An important marker in patients without anti-acetylcholine receptor antibodies in myasthenia gravis disease
Anti-Voltage gated calcium channels: Responsible for Lambert-Eaton myasthenic syndrome (LEMS), a rare autoimmune disorder of the neuromuscular junction
Anti-Voltage gated potassium channels: Downregulate the potassium channels expressed on the peripheral nerve terminal leading to nerve hyperexcitability
Anti-Titin: Present in 70–90% of thymoma autoimmune myasthenia gravis (MG) patients, and in approximately 50% of late-onset acetylcholine-MG patients without thymoma

Brain Autoimmunity

Anti-Purkinje cell: Autoimmunity to a class of GABAergic neurons located in the cerebellum, which can produce abnormalities and decline in gross motor functions
Anti-Yo: Suggest that a patient with neurologic symptoms has a paraneoplastic syndrome. In addition, their presence also often suggests the nature of the underlying tumor.
Anti-Amyloid beta (25-35): Levels of autoantibodies reacting with oligomers of the short, neurotoxic fragment Aβ (25-35) are significantly higher in AD patients than in healthy controls
Anti-Amyloid beta (1-42): A signature marker in Alzheimer’s disease
Anti-RAGE peptide: Found in Alzheimer’s disease patients, and particularly higher in AD patients with diabetes
Anti-Tau: Found in the neurofibrillary tangles in brains of individuals who have Alzheimer’s disease
Anti-Glutamate: Found in epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren’s syndrome, schizophrenia, mania or stroke
Anti-Dopamine: Associated with movement disorders characterized by parkinsonism, dystonia, and Sydenham chorea
Anti-Hydroxytryptamine: Found mainly in autoimmune encephalitis
Anti-Alpha-synuclein: Mainly elevated in Parkinson’s disease and Alzheimer’s disease
Anti-α1 and β2 adrenergic receptors: Found mainly in patients with different dementia forms such as unclassified, Lewy body, vascular, and Alzheimer’s dementia
Anti-Endothelin A receptor: Found in vascular dementia

Brain Inflammation

Anti-NMDA receptor: Found in anti-NMDA receptor encephalitis
Anti-AMPA receptor: May play a role in Alzheimer’s disease, characterized by decreased AMPA activation and synapse loss
Anti-Dopamine receptors: Associated with Parkinson’s disease and other disorders of low dopamine status
Anti-GABA receptors: Associated with temporal lobe epilepsy (TLE), Parkinson’s disease (PD) and Huntington’s disease (HD) and other neurodegenerative disorders that involve disruptions in gamma-amino butyric acid (GABA) signalling
Anti-Dipeptidyl aminopeptidase-like protein 6: Associated with encephalitis
Anti-Glycine receptor: Helpful in the diagnosis of patients with symptoms and signs that include ocular motor and other brainstem dysfunction, hyperekplexia, stiffness, rigidity, myoclonus and spasms
Anti-Neurexin 3: Associated with a severe but potentially treatable encephalitis in which the antibodies cause a decrease of neurexin-3α and alter synapse development
Anti-Contactin-associated protein-like 2: Diseases associated with CNTNAP2 include Pitt-Hopkins-Like Syndrome 1 and Autism 15
Anti-Leucine-rich glioma-inactivated protein 1: LGI1 antibody–associated encephalitis has increasingly been recognized as a primary autoimmune disorder
Anti-Ma: Present in men with testicular tumors and isolated or combined limbic encephalitis (LE), diencephalic encephalitis (DE), or brainstem encephalitis (BE)

Infections

Anti-HSV-1: HSV-1 has been reported to have a pathogenesis role in Herpes simplex encephalitis (HSE) and seropositivity to HSV-1 antibodies has been correlated with increased risk of Alzheimer’s disease
Anti-HSV-2: Herpes simplex encephalitis (HSE) is a disorder commonly associated with HSV-2. HSE due to HSV-2 may occur without meningitis features. Antibodies against HSV-2 have shown positive correlation in patients with symptoms of HSE.
Anti-EBV: Antibodies against the EBV nuclear antigen complex (EBNAc) and EBNA-1 have been correlated with increased risk of multiple sclerosis (MS).
Anti-CMV: Cytomegalovirus (CMV) infections have been reported frequently to be associated with Guillain–Barre syndrome (GBS). There is a potential for molecular mimicry between GM2 and antigens induced by CMV infection.
Anti-HHV-6: Human herpesvirus-6 (HHV-6) is frequently associated with neurologic diseases, including multiple sclerosis (MS), epilepsy, encephalitis, and febrile illness.
Anti-HHV-7: HHV-7 has been less frequently associated with CNS disease than HHV-6, but found to be associated with encephalitis, meningitis, and demyelinating conditions. Similar to HHV 6A, increased levels of HHV-7 were found in multiple brain regions in Alzheimer’s disease (AD) patients.
Anti-Streptococcal A: Anti-streptococcal A antibodies are shown to cross react with different brain proteins that could lead to neuropsychiatric symptoms including PANDAS characterized by paediatric obsessive-compulsive disorder (OCD) and tic disorder, and Sydenham Chorea.

The test pricing includes the mailing of the blood collection kit from the USA, return shipping to the USA, and the lab test analysis in the USA. 

The kit usually takes 14 business days to arrive from the USA. If you have not received your kit within 14 days, please email us at evergreenoptilabs@gmail.com

You may like to arrange a blood collection at our office for a $50 fee, so it just 1 needle, otherwise you can use the home finger prick test kit yourself.

 *Please note - the lab has extended the turn around time for results now to 30 days from receipt at the USA lab *

 **You must send us your Date of Birth for the lab to send your test it, please ensure you do this after you order **

By ordering you acknowledge the test is intended for research, educational, and informational use only. Discuss results with your healthcare provider.